Find Triptorelin Pamoate manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

KDMF

KDMF

0

VMF

NDC API

API REF. PRICE (USD/KG)

MARKET PLACE

0INTERMEDIATES

FDF DossiersDRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 57773-63-4, Triptoreline, Arvekap, (d-trp6)-gnrh, Decapeptyl, Triptorelina
Molecular Formula
C64H82N18O13
Molecular Weight
1311.4  g/mol
InChI Key
VXKHXGOKWPXYNA-PGBVPBMZSA-N

Triptorelin Pamoate
A potent synthetic long-acting agonist of GONADOTROPIN-RELEASING HORMONE with D-tryptophan substitution at residue 6.
1 2D Structure

Triptorelin Pamoate

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
(2S)-N-[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2R)-1-[[(2S)-1-[[(2S)-1-[(2S)-2-[(2-amino-2-oxoethyl)carbamoyl]pyrrolidin-1-yl]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]-5-oxopyrrolidine-2-carboxamide
2.1.2 InChI
InChI=1S/C64H82N18O13/c1-34(2)23-46(56(88)75-45(13-7-21-69-64(66)67)63(95)82-22-8-14-52(82)62(94)72-31-53(65)85)76-58(90)48(25-36-28-70-42-11-5-3-9-40(36)42)78-57(89)47(24-35-15-17-39(84)18-16-35)77-61(93)51(32-83)81-59(91)49(26-37-29-71-43-12-6-4-10-41(37)43)79-60(92)50(27-38-30-68-33-73-38)80-55(87)44-19-20-54(86)74-44/h3-6,9-12,15-18,28-30,33-34,44-52,70-71,83-84H,7-8,13-14,19-27,31-32H2,1-2H3,(H2,65,85)(H,68,73)(H,72,94)(H,74,86)(H,75,88)(H,76,90)(H,77,93)(H,78,89)(H,79,92)(H,80,87)(H,81,91)(H4,66,67,69)/t44-,45-,46-,47-,48+,49-,50-,51-,52-/m0/s1
2.1.3 InChI Key
VXKHXGOKWPXYNA-PGBVPBMZSA-N
2.1.4 Canonical SMILES
CC(C)CC(C(=O)NC(CCCN=C(N)N)C(=O)N1CCCC1C(=O)NCC(=O)N)NC(=O)C(CC2=CNC3=CC=CC=C32)NC(=O)C(CC4=CC=C(C=C4)O)NC(=O)C(CO)NC(=O)C(CC5=CNC6=CC=CC=C65)NC(=O)C(CC7=CN=CN7)NC(=O)C8CCC(=O)N8
2.1.5 Isomeric SMILES
CC(C)C[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N)NC(=O)[C@@H](CC2=CNC3=CC=CC=C32)NC(=O)[C@H](CC4=CC=C(C=C4)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC5=CNC6=CC=CC=C65)NC(=O)[C@H](CC7=CN=CN7)NC(=O)[C@@H]8CCC(=O)N8
2.2 Synonyms
2.2.1 MeSH Synonyms

1. 6-d-tryptophan-luteinizing Hormone-releasing Factor (pig)

2. Ay 25650

3. Ay-25650

4. Ay25650

5. Cl 118532

6. Cl-118532

7. Cl118532

8. D-trp-6-lh-rh

9. Decapeptyl

10. Decapeptyl Depot

11. Decapeptyl Lp

12. Decapeptyl Trimestral

13. Embonate, Triptorelin

14. Gnrh, Trp(6)-

15. Lhrh, Trp(6)-

16. Lhrh, Tryptophyl(6)-

17. Pamoate, Triptorelin

18. Trelstar

19. Trimestral, Decapeptyl

20. Triptorelin Embonate

21. Triptorelin Pamoate

22. Wy 42462

23. Wy-42462

24. Wy42462

2.2.2 Depositor-Supplied Synonyms

1. 57773-63-4

2. Triptoreline

3. Arvekap

4. (d-trp6)-gnrh

5. Decapeptyl

6. Triptorelina

7. Triptorelinum

8. Trelstar

9. Triptodur

10. Diphereline

11. (6-d-tryptophan)luteinizing Hormone-releasing Hormone

12. Cl 118532

13. Cl-118532

14. Pglu-his-trp-ser-tyr-d-trp-leu-arg-pro-gly-nh2

15. Ay-25650

16. Luteinizing Hormone-releasing Factor (pig), 6-d-tryptophan

17. Cl 118,532

18. Chebi:63633

19. Wy 42462

20. Ay 25650

21. Pamorelin

22. Salvacyl

23. Trelstar Depot

24. 5-oxo-l-prolyl-l-histidyl-l-tryptophyl-l-seryl-l-tyrosyl-d-tryptophyl-l-leucyl-l-arginyl-l-prolylglycinamide

25. Trelstar La

26. Luteinizing Hormone-releasing Factor (swine), 6-d-tryptophan-

27. Bim 21003

28. Wy 42422

29. Tryptorelin

30. Diferelin

31. D-tryptophan-lh-rh

32. Triptoreline [inn-french]

33. Triptorelinum [inn-latin]

34. Triptorelina [inn-spanish]

35. Trellasar

36. Moapar

37. Triptorelin [usan:inn:ban]

38. Decapeptyl Sr

39. Pamorelin La

40. Unii-9081y98w2v

41. Triptorelin (swine)

42. Wy-42462

43. D-trp6-lhrh

44. Debio-8206

45. Triptorelin (usan/inn)

46. (d-trp6)-lh-rh

47. Gtpl1177

48. Schembl5079698

49. Chembl1201334

50. Dtxsid2048375

51. Schembl22289009

52. Hms2090c17

53. Ex-a3857

54. Bim-21003

55. Akos030213249

56. 9081y98w2v

57. Cs-5745

58. Db06825

59. Ncgc00167301-01

60. Ncgc00167301-02

61. As-71149

62. Bn-52014

63. Hy-12551

64. 73t634

65. C75704

66. D06247

67. [d-trp6]-lh-rh, >=97% (hplc), Powder

68. Ab01275488-01

69. A936467

70. Pglu-his-trp-ser-tyr-d-trp-leu-arg-pro-glynh2

71. Q1992452

72. (s)-1-((3s,6s,9s,12s,15r,18s,21s)-3-((1h-imidazol-5-yl)methyl)-6,15-bis((1h-indol-3-yl)methyl)-21-(3-guanidinopropyl)-12-(4-hydroxybenzyl)-9-(hydroxymethyl)-18-isobutyl-1,4,7,10,13,16,19-heptaoxo-1-((s)-5-oxopyrrolidin-2-yl)-2,5,8,11,14,17,20-heptaazadocosan-22-oyl)-n-(2-amino-2-oxoethyl)pyrrolidine-2-carboxamide

73. Glycinamide, 5-oxo-l-prolyl-l-histidyl-l-tryptophyl-l-seryl-l-tyrosyl-d-tryptophyl-l-leucyl-l-arginyl-l-prolyl-

2.3 Create Date
2008-12-10
3 Chemical and Physical Properties
Molecular Weight 1311.4 g/mol
Molecular Formula C64H82N18O13
XLogP3-0.3
Hydrogen Bond Donor Count17
Hydrogen Bond Acceptor Count15
Rotatable Bond Count33
Exact Mass1310.63087474 g/mol
Monoisotopic Mass1310.63087474 g/mol
Topological Polar Surface Area490 Ų
Heavy Atom Count95
Formal Charge0
Complexity2710
Isotope Atom Count0
Defined Atom Stereocenter Count9
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Drug and Medication Information
4.1 Drug Information
1 of 2  
Drug NameTrelstar
PubMed HealthTriptorelin (Injection)
Drug ClassesAntineoplastic Agent, Endocrine-Metabolic Agent
Drug LabelTRELSTAR is a white to slightly yellow lyophilized cake. When reconstituted, TRELSTAR has a milky appearance. It contains a pamoate salt of triptorelin, a synthetic decapeptide agonist analog of gonadotropin releasing hormone (GnRH). The chemical...
Active IngredientTriptorelin pamoate
Dosage FormInjectable
RouteIntramuscular
Strengtheq 11.25mg base/vial; eq 3.75mg base/vial; eq 22.5mg base/vial
Market StatusPrescription
CompanyWatson Labs

2 of 2  
Drug NameTrelstar
PubMed HealthTriptorelin (Injection)
Drug ClassesAntineoplastic Agent, Endocrine-Metabolic Agent
Drug LabelTRELSTAR is a white to slightly yellow lyophilized cake. When reconstituted, TRELSTAR has a milky appearance. It contains a pamoate salt of triptorelin, a synthetic decapeptide agonist analog of gonadotropin releasing hormone (GnRH). The chemical...
Active IngredientTriptorelin pamoate
Dosage FormInjectable
RouteIntramuscular
Strengtheq 11.25mg base/vial; eq 3.75mg base/vial; eq 22.5mg base/vial
Market StatusPrescription
CompanyWatson Labs

4.2 Drug Indication

Triptorelin is indicated for the palliative treatment of advanced prostate cancer.


FDA Label


For the synchronisation of ovulation in weaned sows to enable a single fixed-time artificial insemination.


5 Pharmacology and Biochemistry
5.1 Pharmacology

The first administration of triptorelin is followed by a transient surge of follicle stimulating hormone (FSH), luteinizing hormone (LH), estradiol,and testosterone. The time, peak and decline of testosterone in the body varies depending on the dose administered. This initial surge is often responsible for worsening of prostate cancer symptoms such as urethral or bladder outlet obstruction, bone pain, spinal cord injury and hematuria in the early stages. A sustained decrease in FSH and LH, and significant reduction of testicular steroidogenesis is usually seen 2-4 weeks post-initiation of therapy. This result is a reduction of serum testosterone to levels which are typically seen in surgically castrated men. Ultimately, tissues and functions that require these hormones become inactive. The effects of triptorelin can usually be reversed once the drug is discontinued.


5.2 MeSH Pharmacological Classification

Antineoplastic Agents, Hormonal

Antineoplastic agents that are used to treat hormone-sensitive tumors. Hormone-sensitive tumors may be hormone-dependent, hormone-responsive, or both. A hormone-dependent tumor regresses on removal of the hormonal stimulus, by surgery or pharmacological block. Hormone-responsive tumors may regress when pharmacologic amounts of hormones are administered regardless of whether previous signs of hormone sensitivity were observed. The major hormone-responsive cancers include carcinomas of the breast, prostate, and endometrium; lymphomas; and certain leukemias. (From AMA Drug Evaluations Annual 1994, p2079) (See all compounds classified as Antineoplastic Agents, Hormonal.)


Luteolytic Agents

Chemical compounds that cause LUTEOLYSIS or degeneration of the CORPUS LUTEUM. (See all compounds classified as Luteolytic Agents.)


5.3 ATC Code

QH01CA97


L - Antineoplastic and immunomodulating agents

L02 - Endocrine therapy

L02A - Hormones and related agents

L02AE - Gonadotropin releasing hormone analogues

L02AE04 - Triptorelin


5.4 Absorption, Distribution and Excretion

Absorption

Following IV administration of triptorelin, triptorelin is completely absorbed.


Route of Elimination

Elimination of triptorelin involves both the kidneys and the liver.


Volume of Distribution

After a single IV dose of 0.5mg, the volume of distribution of triptorelin peptide in healthy males was 30 - 33L.


Clearance

In healthy male volunteers, total clearance of triptorelin was 211.9 mL/min.


5.5 Metabolism/Metabolites

The metabolism of triptorelin in humans is not well understood; however, metabolism likely does not involve hepatic enzymes such as cytochrome P450. Whether or not triptorelin affects, or how it affects other metabolizing enzymes is also poorly understood. Triptorelin has no identified metabolites.


5.6 Biological Half-Life

The pharmacokinetics of triptorelin follows a 3 compartment model. The half lives are estimated to be 6 minutes, 45 minutes, and 3 hours respectively.


5.7 Mechanism of Action

Triptorelin is a synthetic agonist analog of gonadotropin releasing hormone (GnRH). Animal studies comparing triptorelin to native GnRH found that triptorelin had 13 fold higher releasing activity for luteinizing hormone, and 21-fold higher releasing activity for follicle-stimulating hormone.


NDC API

read-more
read-more

01

Bachem AG

Switzerland
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothBachem Group is a public, innovation-driven company specializing in the development and manufacturing of peptides and oligonucleotides.

Flag Switzerland
Digital Content Digital Content

TRIPTORELIN PAMOATE

NDC Package Code : 55463-0006

Start Marketing Date : 2006-06-21

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (1g/g)

Marketing Category : BULK INGREDIENT

Bachem company banner

02

BIO CEO & Investor
Not Confirmed
arrow
arrow
BIO CEO & Investor
Not Confirmed

TRIPTORELIN PAMOATE

NDC Package Code : 62788-437

Start Marketing Date : 2010-10-03

End Marketing Date : 2025-12-31

Dosage Form (Strength) : INJECTION, POWDER, FOR SUSPENSION (22.5mg/2mL)

Marketing Category : DRUG FOR FURTHER PROCESSING

blank

03

BIO CEO & Investor
Not Confirmed
arrow
arrow
BIO CEO & Investor
Not Confirmed

TRIPTORELIN PAMOATE

NDC Package Code : 62788-956

Start Marketing Date : 2017-06-29

End Marketing Date : 2025-12-31

Dosage Form (Strength) : INJECTION, POWDER, FOR SUSPENSION, EXTENDED RELEASE (22.5mg/2mL)

Marketing Category : DRUG FOR FURTHER PROCESSING

blank

04

BIO CEO & Investor
Not Confirmed
arrow
arrow
BIO CEO & Investor
Not Confirmed

TRIPTORELIN PAMOATE

NDC Package Code : 62788-288

Start Marketing Date : 2001-06-29

End Marketing Date : 2025-12-31

Dosage Form (Strength) : INJECTION, POWDER, FOR SUSPENSION (11.25mg/2mL)

Marketing Category : DRUG FOR FURTHER PROCESSING

blank

05

BIO CEO & Investor
Not Confirmed
arrow
arrow
BIO CEO & Investor
Not Confirmed

TRIPTORELIN PAMOATE

NDC Package Code : 62788-715

Start Marketing Date : 2000-06-15

End Marketing Date : 2025-12-31

Dosage Form (Strength) : INJECTION, POWDER, FOR SUSPENSION (3.75mg/2mL)

Marketing Category : DRUG FOR FURTHER PROCESSING

blank

06

BIO CEO & Investor
Not Confirmed
arrow
arrow
BIO CEO & Investor
Not Confirmed

TRIPTORELIN

NDC Package Code : 59149-006

Start Marketing Date : 2023-02-20

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (500g/500g)

Marketing Category : BULK INGREDIENT

blank

07

BIO CEO & Investor
Not Confirmed
arrow
arrow
BIO CEO & Investor
Not Confirmed

TRIPTORELIN PAMOATE

NDC Package Code : 71161-103

Start Marketing Date : 2000-06-15

End Marketing Date : 2024-12-31

Dosage Form (Strength) : INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION (3.75mg/2mL)

Marketing Category : DRUG FOR FURTHER PROCESSING

blank

08

BIO CEO & Investor
Not Confirmed
arrow
arrow
BIO CEO & Investor
Not Confirmed

TRIPTORELIN PAMOATE

NDC Package Code : 71161-105

Start Marketing Date : 2010-03-11

End Marketing Date : 2024-12-31

Dosage Form (Strength) : INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION (22.5mg/2mL)

Marketing Category : DRUG FOR FURTHER PROCESSING

blank

09

BIO CEO & Investor
Not Confirmed
arrow
arrow
BIO CEO & Investor
Not Confirmed

TRIPTORELIN PAMOATE

NDC Package Code : 71161-104

Start Marketing Date : 2001-06-29

End Marketing Date : 2024-12-31

Dosage Form (Strength) : INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION (11.25mg/2mL)

Marketing Category : DRUG FOR FURTHER PROCESSING

blank

10

BIO CEO & Investor
Not Confirmed
arrow
arrow
BIO CEO & Investor
Not Confirmed

TRIPTORELIN

NDC Package Code : 71161-106

Start Marketing Date : 2017-09-08

End Marketing Date : 2024-12-31

Dosage Form (Strength) : INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION (22.5mg/2mL)

Marketing Category : DRUG FOR FURTHER PROCESSING

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

API Reference Price

read-more
read-more
[{"dataSource":"API Export","activeIngredients":"","year":"2021","qtr":"Q4","strtotime":1636309800,"product":"PEPTIDES TRIPTORELIN (QTY 500 GRAMS)","address":"403\/404, SIGMA, HIRANANDANI GARDENSPOWAI, MUMBAI,","city":"MAHARASHTRA","supplier":"POLYPEPTIDE GROUP","supplierCountry":"INDIA","foreign_port":"MILAN","customer":"TO THE ORDER OF","customerCountry":"ITALY","quantity":"0.50","actualQuantity":"0.5","unit":"KGS","unitRateFc":"120000","totalValueFC":"68442.5","currency":"EUR","unitRateINR":10194000,"date":"08-Nov-2021","totalValueINR":"5097000","totalValueInUsd":"68442.5","indian_port":"BOMBAY AIR","hs_no":"29371900","bill_no":"5853746","productDescription":"API","marketType":"REGULATED MARKET","country":"ITALY","selfForZScoreResived":"Pharma Grade","supplierPort":"BOMBAY AIR","supplierAddress":"403\/404, SIGMA, HIRANANDANI GARDENSPOWAI, MUMBAI,, MAHARASHTRA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q1","strtotime":1677695400,"product":"TRIPTORELIN IH PEPTIDES (NON HAZ PHARMA","address":"PLOT NO K-28,ADDITIONAL MIDC,,ANAN D NAGAR,","city":"AMBERNATH EAST,MAHARASHTRA","supplier":"POLYPEPTIDE GROUP","supplierCountry":"INDIA","foreign_port":"MALMO","customer":"POLYPEPTIDE GROUP","customerCountry":"SWEDEN","quantity":"0.00","actualQuantity":"0.3","unit":"GMS","unitRateFc":"220","totalValueFC":"72.9","currency":"EUR","unitRateINR":20000,"date":"02-Mar-2023","totalValueINR":"6000","totalValueInUsd":"72.9","indian_port":"BOMBAY AIR","hs_no":"29371900","bill_no":"8181495","productDescription":"API","marketType":"REGULATED MARKET","country":"SWEDEN","selfForZScoreResived":"Pharma Grade","supplierPort":"BOMBAY AIR","supplierAddress":"PLOT NO K-28,ADDITIONAL MIDC,,ANAN D NAGAR,, AMBERNATH EAST,MAHARASHTRA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q3","strtotime":1693333800,"product":"PEPTIDES- TRIPTORELIN PAMOATE ITEM NO.","address":"PLOT NO K-28ADDITIONAL MIDCANAN D NAGAR","city":"AMBERNATH","supplier":"POLYPEPTIDE GROUP","supplierCountry":"INDIA","foreign_port":"SEOUL","customer":"Z TO ORDER AND NA","customerCountry":"KOREA, REPUBLIC OF","quantity":"0.03","actualQuantity":"30","unit":"GMS","unitRateFc":"400","totalValueFC":"12818.9","currency":"EUR","unitRateINR":35395.731,"date":"30-Aug-2023","totalValueINR":"1061871.93","totalValueInUsd":"12818.9","indian_port":"BOMBAY AIR","hs_no":"29371900","bill_no":"0","productDescription":"API","marketType":"REGULATED MARKET","country":"SOUTH KOREA","selfForZScoreResived":"Pharma Grade","supplierPort":"BOMBAY AIR","supplierAddress":"PLOT NO K-28ADDITIONAL MIDCANAN D NAGAR, AMBERNATH","customerAddress":""},{"dataSource":"API Import","activeIngredients":"TRIPTORELIN ACETATE","year":"2021","qtr":"Q2","strtotime":1618252200,"product":"TRIPTORELIN ACETATE","address":"","city":"","supplier":"CIP GLOBAL CO., LTD","supplierCountry":"CHINA","foreign_port":"NANJING","customer":"BIOZENTA LIFESCIENCE PRIVATE ","customerCountry":"INDIA","quantity":"0.09","actualQuantity":"85","unit":"GMS","unitRateFc":"109","totalValueFC":"9227.8","currency":"USD","unitRateINR":"8082.4","date":"13-Apr-2021","totalValueINR":"686999.75","totalValueInUsd":"9227.8","indian_port":"DELHI AIR","hs_no":"29371900","bill_no":"3551366","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"NANJING","supplierAddress":"","customerAddress":""},{"dataSource":"API Import","activeIngredients":"TRIPTORELIN ACETATE","year":"2021","qtr":"Q2","strtotime":1621189800,"product":"TRIPTORELIN ACETATE","address":"","city":"","supplier":"BACHEM AG","supplierCountry":"SWITZERLAND","foreign_port":"FRANKFURT\/MAIN INT\\'L","customer":"BIOZENTA LIFESCIENCE PRIVATE ","customerCountry":"INDIA","quantity":"0.21","actualQuantity":"213.1","unit":"GMS","unitRateFc":"615","totalValueFC":"135307.2","currency":"USD","unitRateINR":"46509.5","date":"17-May-2021","totalValueINR":"9911166.34","totalValueInUsd":"135307.2","indian_port":"DELHI AIR","hs_no":"29371900","bill_no":"3969199","productDescription":"API","marketType":"REGULATED MARKET","country":"SWITZERLAND","selfForZScoreResived":"Pharma Grade","supplierPort":"FRANKFURT\/MAIN INT\\'L","supplierAddress":"","customerAddress":""},{"dataSource":"API Import","activeIngredients":"","year":"2023","qtr":"Q4","strtotime":1703269800,"product":"TRIPTORELIN PAMOATE","address":"101, SITARAM MANSION,","city":"KAROL BAGH, NEW DELHI","supplier":"SHENZHEN JYMED TECHNOLOGY","supplierCountry":"CHINA","foreign_port":"GUANGZHOU","customer":"JODAS EXPOIM PVT. LTD","customerCountry":"INDIA","quantity":"0.03","actualQuantity":"0.03","unit":"KGS","unitRateFc":"350000","totalValueFC":"10570.2","currency":"USD","unitRateINR":"29330000","date":"23-Dec-2023","totalValueINR":"879900","totalValueInUsd":"10570.2","indian_port":"Hyderabad Air","hs_no":"29371900","bill_no":"9372624","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"GUANGZHOU","supplierAddress":"RM 806-810 1# 8\/F BIOMEDICINE INNOVATION INDUSTRIAL PARKSDNF China","customerAddress":"101, SITARAM MANSION,"},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q1","strtotime":1705602600,"product":"TRIPTORELIN ACETATE ( 25G)","address":"101, SITARAM MANSION,","city":"KAROL BAGH, NEW DELHI","supplier":"CHINESE PEPTIDE CO LTD","supplierCountry":"CHINA","foreign_port":"BEIJING","customer":"JODAS EXPOIM PVT. LTD","customerCountry":"INDIA","quantity":"0.03","actualQuantity":"0.025","unit":"KGS","unitRateFc":"470000","totalValueFC":"11889.7","currency":"USD","unitRateINR":"39527000","date":"19-Jan-2024","totalValueINR":"988175","totalValueInUsd":"11889.7","indian_port":"Hyderabad Air","hs_no":"29371900","bill_no":"9728108","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"BEIJING","supplierAddress":"NO.69 12TH STREET HANGZHOU ECONOMIC& TECHNOLOGICAL DEVELOPMENT ZONESDNF China","customerAddress":"101, SITARAM MANSION,"}]
13-Apr-2021
19-Jan-2024
KGS
overview
Loading...

Average Price (USD/KGS)

Number of Transactions

Total Quantity (KGS)

Total Value (USD)

Quantity (KGS) & Unit rate (USD/KGS) over time

API Imports and Exports

Importing Country Total Quantity
(KGS)
Average Price
(USD/KGS)
Number of Transactions

Upgrade, download data, analyse, strategize, subscribe with us contact

Drugs in Development

read-more
read-more

Details:

Debiopharm to enter into this new alliance with Aspen, a well-established and trusted pharmaceutical partner for the commercialization of Trelstar® in South Africa and recognize the therapeutic benefits that Trelstar® could bring to prostate cancer patients in this region.


Lead Product(s): Triptorelin Pamoate

Therapeutic Area: Oncology Brand Name: Trelstar

Study Phase: ApprovedProduct Type: Peptide

Sponsor: Debiopharm

Deal Size: Undisclosed Upfront Cash: Undisclosed

Deal Type: Partnership February 01, 2022

Aspen API Comapny Banner

01

RNA Therapeutics
Not Confirmed

Details : Debiopharm to enter into this new alliance with Aspen, a well-established and trusted pharmaceutical partner for the commercialization of Trelstar® in South Africa and recognize the therapeutic benefits that Trelstar® could bring to prostate cancer pat...

Product Name : Trelstar

Product Type : Peptide

Upfront Cash : Undisclosed

February 01, 2022

Aspen API Comapny Banner

Details:

The net proceeds will be allocated to advancing the company’s pipeline, including FP-014 (triptorelin), a ready-to-use, long-acting injectable developed for the treatment of prostate cancer.


Lead Product(s): Triptorelin Pamoate

Therapeutic Area: Oncology Brand Name: FP-014

Study Phase: Phase IIProduct Type: Peptide

Sponsor: Undisclosed

Deal Size: $42.1 million Upfront Cash: Undisclosed

Deal Type: Financing December 04, 2024

blank

02

BIO CEO & Investor
Not Confirmed
BIO CEO & Investor
Not Confirmed

Details : The net proceeds will be allocated to advancing the company’s pipeline, including FP-014 (triptorelin), a ready-to-use, long-acting injectable developed for the treatment of prostate cancer.

Product Name : FP-014

Product Type : Peptide

Upfront Cash : Undisclosed

December 04, 2024

blank

Details:

Debio 4326 is a unique injectable, biodegradable 12-month extended-release formulation of triptorelin, being developed for pediatric participants for central precocious puberty.


Lead Product(s): Triptorelin Pamoate

Therapeutic Area: Endocrinology Brand Name: Debio 4326

Study Phase: Phase IIIProduct Type: Peptide

Sponsor: Not Applicable

Deal Size: Not Applicable Upfront Cash: Not Applicable

Deal Type: Not Applicable September 09, 2024

blank

03

Debiopharm

Switzerland
arrow
BIO CEO & Investor
Not Confirmed

Debiopharm

Switzerland
arrow
BIO CEO & Investor
Not Confirmed

Details : Debio 4326 is a unique injectable, biodegradable 12-month extended-release formulation of triptorelin, being developed for pediatric participants for central precocious puberty.

Product Name : Debio 4326

Product Type : Peptide

Upfront Cash : Not Applicable

September 09, 2024

blank

Details:

Dexa Medica’s nation-wide launch and distribution of triptorelin, as Debiopharm’s exclusive Indonesian licensee, will help patients in the region gain access to the pain-relieving benefits of hormone suppression with Pamorelin®.


Lead Product(s): Triptorelin Pamoate

Therapeutic Area: Obstetrics/Gynecology (Women’s Health) Brand Name: Pamorelin

Study Phase: ApprovedProduct Type: Large molecule

Sponsor: Debiopharm

Deal Size: Undisclosed Upfront Cash: Undisclosed

Deal Type: Collaboration October 07, 2021

blank

04

Dexa Medica

Indonesia
arrow
BIO CEO & Investor
Not Confirmed

Dexa Medica

Indonesia
arrow
BIO CEO & Investor
Not Confirmed

Details : Dexa Medica’s nation-wide launch and distribution of triptorelin, as Debiopharm’s exclusive Indonesian licensee, will help patients in the region gain access to the pain-relieving benefits of hormone suppression with Pamorelin®.

Product Name : Pamorelin

Product Type : Large molecule

Upfront Cash : Undisclosed

October 07, 2021

blank

Details:

The companies have entered into an exclusive agreement that grants Verity Pharmaceuticals Inc. the rights to commercialize Trelstar® (triptorelin pamoate for injectable suspension), a hormone therapy for patients living with prostate cancer.


Lead Product(s): Triptorelin Pamoate

Therapeutic Area: Oncology Brand Name: Trelstar

Study Phase: ApprovedProduct Type: Large molecule

Sponsor: Verity Pharmaceuticals Inc

Deal Size: Undisclosed Upfront Cash: Undisclosed

Deal Type: Agreement June 09, 2020

blank

05

Debiopharm

Switzerland
arrow
BIO CEO & Investor
Not Confirmed

Debiopharm

Switzerland
arrow
BIO CEO & Investor
Not Confirmed

Details : The companies have entered into an exclusive agreement that grants Verity Pharmaceuticals Inc. the rights to commercialize Trelstar® (triptorelin pamoate for injectable suspension), a hormone therapy for patients living with prostate cancer.

Product Name : Trelstar

Product Type : Large molecule

Upfront Cash : Undisclosed

June 09, 2020

blank

Details:

The agreement grants Knight the rights to commercialize Trelstar® (triptorelin) in Canada.


Lead Product(s): Triptorelin Pamoate

Therapeutic Area: Oncology Brand Name: Undisclosed

Study Phase: ApprovedProduct Type: Small molecule

Sponsor: Knight Therapeutics

Deal Size: Undisclosed Upfront Cash: Undisclosed

Deal Type: Partnership January 08, 2020

blank

06

Debiopharm

Switzerland
arrow
BIO CEO & Investor
Not Confirmed

Debiopharm

Switzerland
arrow
BIO CEO & Investor
Not Confirmed

Details : The agreement grants Knight the rights to commercialize Trelstar® (triptorelin) in Canada.

Product Name : Undisclosed

Product Type : Small molecule

Upfront Cash : Undisclosed

January 08, 2020

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

FDF Dossiers

read-more
read-more

01

arrow
RNA Therapeutics
Not Confirmed

Triptorelin

Brand Name : Trelstar LA 3,75 mg

Dosage Form : POI

Dosage Strength : 3.75mg

Packaging : 2X1mg

Approval Date :

Application Number :

Regulatory Info : Originator

Registration Country : South Africa

Aspen API Comapny Banner

02

arrow
RNA Therapeutics
Not Confirmed

Triptorelin

Brand Name : Trelstar LA 11,25 mg

Dosage Form : POI

Dosage Strength : 11.25mg

Packaging : 2X1mg

Approval Date :

Application Number :

Regulatory Info : Originator

Registration Country : South Africa

Aspen API Comapny Banner

03

arrow
BIO CEO & Investor
Not Confirmed

Triptorelin

Brand Name : Trelstar LA 22,5 mg

Dosage Form : POI

Dosage Strength : 22.5mg

Packaging : 2X1mg

Approval Date :

Application Number :

Regulatory Info : Originator

Registration Country : South Africa

Aspen API Comapny Banner

04

Debiopharm

Switzerland
RNA Therapeutics
Not Confirmed
arrow

Debiopharm

Switzerland
arrow
RNA Therapeutics
Not Confirmed

Triptorelinum

Brand Name : Pamorelin LA

Dosage Form : Trockensub

Dosage Strength : 11.25mg

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Switzerland

blank

05

Debiopharm

Switzerland
RNA Therapeutics
Not Confirmed
arrow

Debiopharm

Switzerland
arrow
RNA Therapeutics
Not Confirmed

Triptorelinum

Brand Name : Salvacyl

Dosage Form : Trockensub

Dosage Strength : 11.25mg

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Switzerland

blank

06

RNA Therapeutics
Not Confirmed
arrow
arrow
RNA Therapeutics
Not Confirmed

Triptorelin

Brand Name : Gonapeptyl

Dosage Form : Injection fluid, resolution

Dosage Strength : 0.1 mg/ml

Packaging : Finish filled syringe

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

blank

07

Ipsen

France
RNA Therapeutics
Not Confirmed
arrow

Ipsen

France
arrow
RNA Therapeutics
Not Confirmed

Triptorelin

Brand Name : Decapeptyl

Dosage Form : Tryptoreline 3,75Mg 1 Unit Parenteral Use

Dosage Strength : 1 vial IM 3.75 mg + 1 ampoule solv 2 ml + 1 syringe

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

blank

08

Ipsen

France
RNA Therapeutics
Not Confirmed
arrow

Ipsen

France
arrow
RNA Therapeutics
Not Confirmed

triptorelin

Brand Name : Diphereline

Dosage Form :

Dosage Strength :

Packaging : 1

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank

09

Country
BIO CEO & Investor
Not Confirmed
arrow

Country
arrow
BIO CEO & Investor
Not Confirmed

triptorelinembonat

Brand Name : Moapar

Dosage Form : PULVER OCH VÄTSKA TILL INJEKTIONSVÄTSKA

Dosage Strength : 11,25 MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Sweden

blank

10

Country
RNA Therapeutics
Not Confirmed
arrow

Country
arrow
RNA Therapeutics
Not Confirmed

triptorelinembonat

Brand Name : Pamorelin

Dosage Form : POWDER AND SOLVENT FOR SOLUTION FOR INJECTION

Dosage Strength : 3.75 MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Sweden

blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

DRUG PRODUCT COMPOSITIONS

Do you need Business Intel? Ask us

DOSAGE - INJECTABLE;INTRAMUSCULAR - EQ 3.75MG...DOSAGE - INJECTABLE;INTRAMUSCULAR - EQ 3.75MG BASE/VIAL

USFDA APPLICATION NUMBER - 20715

read-more

DOSAGE - INJECTABLE;INTRAMUSCULAR - EQ 11.25M...DOSAGE - INJECTABLE;INTRAMUSCULAR - EQ 11.25MG BASE/VIAL

USFDA APPLICATION NUMBER - 21288

read-more

DOSAGE - INJECTABLE;INTRAMUSCULAR - EQ 22.5MG...DOSAGE - INJECTABLE;INTRAMUSCULAR - EQ 22.5MG BASE/VIAL

USFDA APPLICATION NUMBER - 22437

read-more

Related Excipient Companies

Upload your portfolio for free, ask us

Excipients by Applications

Click here to find the perfect excipient manufacturers by their capabilities

Fillers, Diluents & Binders

read-more
read-more

Solubilizers

read-more
read-more

Chewable & Orodispersible Aids

read-more
read-more

Direct Compression

read-more
read-more

Thickeners and Stabilizers

read-more
read-more

Parenteral

read-more
read-more

Taste Masking

read-more
read-more

Rheology Modifiers

read-more
read-more

Co-Processed Excipients

read-more
read-more

Disintegrants & Superdisintegrants

read-more
read-more

Film Formers & Plasticizers

read-more
read-more

Granulation

read-more
read-more

Topical

read-more
read-more

Emulsifying Agents

read-more
read-more

Coating Systems & Additives

read-more
read-more

API Stability Enhancers

read-more
read-more

Surfactant & Foaming Agents

read-more
read-more

Digital Content read-more

Create Content with PharmaCompass, ask us

DATA COMPILATION #PharmaFlow

read-more
read-more

NEWS #PharmaBuzz

read-more
read-more

Global Sales Information

Do you need Business Intel? Ask us

Market Place

Do you need sourcing support? Ask us

Patents & EXCLUSIVITIES

Check the patents & exclusivity for this product

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Diphereline Manufacturers

A Diphereline manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Diphereline, including repackagers and relabelers. The FDA regulates Diphereline manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Diphereline API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Diphereline manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

Diphereline Suppliers

A Diphereline supplier is an individual or a company that provides Diphereline active pharmaceutical ingredient (API) or Diphereline finished formulations upon request. The Diphereline suppliers may include Diphereline API manufacturers, exporters, distributors and traders.

click here to find a list of Diphereline suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

Diphereline USDMF

A Diphereline DMF (Drug Master File) is a document detailing the whole manufacturing process of Diphereline active pharmaceutical ingredient (API) in detail. Different forms of Diphereline DMFs exist exist since differing nations have different regulations, such as Diphereline USDMF, ASMF (EDMF), JDMF, CDMF, etc.

A Diphereline DMF submitted to regulatory agencies in the US is known as a USDMF. Diphereline USDMF includes data on Diphereline's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Diphereline USDMF is kept confidential to protect the manufacturer’s intellectual property.

click here to find a list of Diphereline suppliers with USDMF on PharmaCompass.

Diphereline WC

A Diphereline written confirmation (Diphereline WC) is an official document issued by a regulatory agency to a Diphereline manufacturer, verifying that the manufacturing facility of a Diphereline active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Diphereline APIs or Diphereline finished pharmaceutical products to another nation, regulatory agencies frequently require a Diphereline WC (written confirmation) as part of the regulatory process.

click here to find a list of Diphereline suppliers with Written Confirmation (WC) on PharmaCompass.

Diphereline NDC

National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Diphereline as an active pharmaceutical ingredient (API).

Finished drug products

The FDA updates the NDC directory daily. The NDC numbers for Diphereline API and other APIs are published in this directory by the FDA.

Unfinished drugs

The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

Pharmaceutical companies that manufacture Diphereline as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

Compounded drug products

The NDC directory also contains data on finished compounded human drug products that contain Diphereline and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Diphereline NDC to their finished compounded human drug products, they may choose to do so.

click here to find a list of Diphereline suppliers with NDC on PharmaCompass.

Diphereline GMP

Diphereline Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

PharmaCompass offers a list of Diphereline GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Diphereline GMP manufacturer or Diphereline GMP API supplier for your needs.

Diphereline CoA

A Diphereline CoA (Certificate of Analysis) is a formal document that attests to Diphereline's compliance with Diphereline specifications and serves as a tool for batch-level quality control.

Diphereline CoA mostly includes findings from lab analyses of a specific batch. For each Diphereline CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

Diphereline may be tested according to a variety of international standards, such as European Pharmacopoeia (Diphereline EP), Diphereline JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Diphereline USP).

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty